http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Deore, Girish D.,Gurav, Abhijit N.,Patil, Rahul,Shete, Abhijeet R.,NaikTari, Ritam S.,Inamdar, Saurabh P. Korean Academy of Periodontology 2014 Journal of Periodontal & Implant Science Vol.44 No.1
Purpose: Periodontitis is an infectious disease caused predominantly by gram-negative anerobes. The host inflammatory response to these bacteria causes alveolar bone loss that is characterized as periodontitis. Omega-3 fatty acids (${\omega}$-3 FAs) have anti-inflammatory properties, thus have been used to treat some chronic inflammatory diseases such as cardiovascular disease and rheumatoid arthritis. We aimed to evaluate the effect of dietary supplementation with ${\omega}$-3 FAs as a host modulating agent in patients with chronic periodontitis. Methods: Sixty otherwise healthy subjects with moderate and severe chronic periodontitis were enrolled in our randomised, double-blind, placebo-controlled trial. The control group (CG, n=30) was treated with scaling and root planing (SRP) and given a placebo; the treatment group (TG, n=30) was treated with SRP and dietary supplementation of ${\omega}$-3 FAs (one 300 mg tablet daily for 12 weeks). Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluated in all patients at baseline, a 6-week and 12-week period after treatment. Results: A significant reduction in the gingival index, sulcus bleeding index, pocket depth, and clinical attachment level was found in the TG compared to the CG at a 12-week period. However, no statistically significant changes in serum CRP levels were found. Conclusions: Our findings suggest that ${\omega}$-3 FAs can successfully reduce gingival inflammation, pocket depth, and attachment level gain. Dietary supplementation with ${\omega}$-3 FAs may have potential benefits as a host modulatory agent in the prevention and/or C management of chronic periodontitis.
Deore, Girish D.,Gurav, Abhijit N.,Patil, Rahul,Shete, Abhijeet R.,Naiktari, Ritam S.,Inamdar, Saurabh P. Korean Academy of Periodontology 2014 Journal of Periodontal & Implant Science Vol.44 No.2
Purpose: Host modulatory therapy has been proposed as a treatment for periodontal diseases. A class of herbal medicines, known to be immunomodulators, alters the activity of immune function through the regulation of informational molecules such as cytokines. In the current study, we tested the hypothesis that herbal immunomodulator drugs act as an adjuvant to scaling and root planing (SRP) in alleviating periodontal inflammation by improving clinical and biochemical parameters. Methods: Sixty healthy subjects (30 in each group) with moderate and severe chronic periodontitis were enrolled in a double-blind, placebo-controlled, double-masked randomised controlled trial. The control group was treated with SRP and a placebo, whereas the test group was treated with SRP followed by dietary supplementation of Septilin for 3 weeks. Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluated for all patients at the baseline, 3 weeks, and 6 weeks. Results: Improved gingival index scores found in the test group as compared to the control group were found to be statistically significant only after 3 weeks (P<0.001). In contrast, the decrease in the sulcus bleeding index and pocket depth scores was statistically highly significant in the test group as compared to the control group after 3 weeks and 6 weeks (P<0.001). However, reduced clinical attachment level and CRP scores, as reflected in the test group as compared to the control group, were not found to be statistically significant after both 3 weeks (P>0.05) and 6 weeks (P>0.05). Conclusions: The results of this clinical-biochemical study suggest that dietary supplementation with herbal immunomodulatory agents may be a promising adjunct to SRP and may aid in improving periodontal treatment outcomes.
Girish D. Deore,Abhijit N. Gurav,Rahul Patil,Abhijeet R. Shete,Ritam S. Naiktari,Saurabh P. Inamdar 대한치주과학회 2014 Journal of Periodontal & Implant Science Vol.44 No.2
Purpose: Host modulatory therapy has been proposed as a treatment for periodontal diseases. A class of herbal medicines, known to be immunomodulators, alters the activity ofimmune function through the regulation of informational molecules such as cytokines. Inthe current study, we tested the hypothesis that herbal immunomodulator drugs act as anadjuvant to scaling and root planing (SRP) in alleviating periodontal inflammation by improvingclinical and biochemical parameters. Methods: Sixty healthy subjects (30 in each group) with moderate and severe chronic periodontitiswere enrolled in a double-blind, placebo-controlled, double-masked randomisedcontrolled trial. The control group was treated with SRP and a placebo, whereas the testgroup was treated with SRP followed by dietary supplementation of Septilin for 3 weeks. Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluatedfor all patients at the baseline, 3 weeks, and 6 weeks. Results: Improved gingival index scores found in the test group as compared to the controlgroup were found to be statistically significant only after 3 weeks (P<0.001). In contrast,the decrease in the sulcus bleeding index and pocket depth scores was statistically highlysignificant in the test group as compared to the control group after 3 weeks and 6 weeks(P<0.001). However, reduced clinical attachment level and CRP scores, as reflected in thetest group as compared to the control group, were not found to be statistically significantafter both 3 weeks (P>0.05) and 6 weeks (P>0.05). Conclusions: The results of this clinical-biochemical study suggest that dietary supplementationwith herbal immunomodulatory agents may be a promising adjunct to SRP and mayaid in improving periodontal treatment outcomes.
Girish D. Deore,Abhijit N. Gurav,Rahul Patil,Abhijeet R. Shete,Ritam S. NaikTari,Saurabh P. Inamdar 대한치주과학회 2014 Journal of Periodontal & Implant Science Vol.44 No.1
Purpose: Periodontitis is an infectious disease caused predominantly by gram-negative anerobes. The host inflammatory response to these bacteria causes alveolar bone loss that ischaracterized as periodontitis. Omega-3 fatty acids (ω-3 FAs) have anti-inflammatory properties,thus have been used to treat some chronic inflammatory diseases such as cardiovasculardisease and rheumatoid arthritis. We aimed to evaluate the effect of dietary supplementationwith ω-3 FAs as a host modulating agent in patients with chronic periodontitis. Methods: Sixty otherwise healthy subjects with moderate and severe chronic periodontitiswere enrolled in our randomised, double-blind, placebo-controlled trial. The control group(CG, n=30) was treated with scaling and root planing (SRP) and given a placebo; thetreatment group (TG, n=30) was treated with SRP and dietary supplementation of ω-3FAs (one 300 mg tablet daily for 12 weeks). Periodontal clinical parameters and serum Creactiveprotein (CRP) levels were evaluated in all patients at baseline, a 6-week and 12-week period after treatment. Results: A significant reduction in the gingival index, sulcus bleeding index, pocket depth,and clinical attachment level was found in the TG compared to the CG at a 12-week period. However, no statistically significant changes in serum CRP levels were found. Conclusions: Our findings suggest that ω-3 FAs can successfully reduce gingival inflammation,pocket depth, and attachment level gain. Dietary supplementation with ω-3 FAsmay have potential benefits as a host modulatory agent in the prevention and/or adjunctivemanagement of chronic periodontitis.